No Detail Found!

Biatractylolide reduced amyloid beta protein-induced memory impairment in rats

Author(s)
Tian-Yi Zhao Changchun University of Chinese Medicine,Changchun 130117,China
Zi-Qing Liu Changchun University of Technology,Changchun 130012,China
Shu-Fei Ma Sinopharm A-Think pharmaceutical Co., Ltd.,Changchun 130000,China
Bo-Yang Changchun University of Chinese Medicine,Changchun 130117,China
Fan-Fan Guo Changchun University of Chinese Medicine,Changchun 130117,China
Ming-Hua Duan Changchun University of Chinese Medicine,Changchun 130117,China
Abstract
Biatractylolide is a Chinese medicinal compound used to treat various diseases. However, the molecular mechanisms of biatractylolide in preventing and protecting Alzheimer's disease (AD) remained elusive. This study was conducted to observe the effect of biatractylolide on the pathological changes of amyloid beta protein (Aß)-induced AD. In vitro assays (MTT and flow cytometry) were applied to detect the effect of biatractylolide on PC12 cell proliferation, growth inhibition rate and apoptosis. In order to assess the spatial learning and memory abilities of AD rats, Morris water maze model was applied in vivo, and the activity of the NF-κB signaling pathway and concentrations of TNF-a, IL-6, and IL-1ß were measured. The results demonstrated that biatractylolide can reduce apoptosis in hippocampal cells, prevent and improve the cognitive decline induced by Aß, prevent the morphological changes in hippocampal nerve cells and can reduce the activation of NF-κB signal pathway in vivo. Taken together, biatractylolide appeared to be a useful agent for the treatment of Aß-related pathologies in the central nervous system, and can be considered for therapeutic application in AD-affected patients.
Publication Details
Page(s) 1031-1038
Published Journal: Pakistan Journal of Zoology, Volume: 52, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
Alzheimer's Disease, Neuroinflammation, Biatractylolide
0

Citations

0

Downloads

90

Views